FDA approved the use of a new fluoroquinolone antibiotic to treat ABSSSI.
Adamis’ epinephrine injection promises to be a lower-cost alterative to EpiPen.
Potential public health consquences prompts FDA to request removal of opioid pain medication.
The first generic Truvada for treating and preventing HIV will be available, but when?
FDA approves Isentress at a higher dose for HIV-1 infected patients.
A new trial for AstraZeneca’s benralizumab shows promising results for severe asthma patients.
FDA has approved the first generic versions of Strattera (atomoxetine) for the treatment of attention deficit/hyperactivity disorder.
Lilly's galcanezumab proves successful in three phase 3 migraine studies. Here are the findings.
AstraZeneca voluntarily recalls professional samples of its antiplatelet agent. Here's what to do.